Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-Limonene for Xerostomia Prevention in HNSCC
NCT04392622Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Feb 2021
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Limonene in xerostomia (7 arms), sponsored by Stanford University. Primary endpoint: Dose Limiting Toxicity at 9 weeks. Started Feb 2021; status: recruiting.
02
Drugs
Limonene
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT04392622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392622.